Multi-modal AI models for intermediate- to high-risk localized prostate cancer
NRG Oncology investigators analyzed clinical and digital histopathology data from five Phase III prostate cancer trials (NRG/RTOG 9202, 9408, 9413, 9910, and 0126) to develop and validate multi-modal intelligence models (MMAI) ...
Oct 25, 2022
0
38
